SARS-CoV-2 Nucleocapsid Fc Protein
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Nucleocapsid Fc Protein is a recombinant protein expressed in Mammalian cells fused to a C-terminal human IgG1-Fc tag with a Tobacco Etch Virus (TEV) sequence linker.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
The SARS-CoV-2 Nucleoprotein (also known as Nucleocapsid Protein or N Protein) is a protein that binds to the RNA in the viral particle. Changes to two amino acids in the nucleoprotein are thought to contribute to the virus’ ability to infect humans; this mutation allows the virus to reduce the binding capability of an HLA-C allele found in many Europeans. The nucleoprotein is the second most-common protein in SARS-CoV-2 targeted by the immune system, after the spike protein.
Supplier | Abbexa Ltd. |
---|---|
Product # | abx620003-1MG |
Pricing | 1 mg USD $1537.0 |
Conjugation | Unconjugated |
Host | Mammalian cells |
Dry Ice | No |
Availability | Shipped within 1-2 months. |
Note | This product is for research use only. |